Teva Pharmaceutical Industries

(OTC) TEVJF

Current Price$30.19

Market Cap$35.16B

Since IPO (2003)-45%

5 Year+188%

1 Year+87%

1 Month+6%

Teva Pharmaceutical Industries Financials at a Glance

Market Cap

$35.16B

Revenue (TTM)

$17.35B

Net Income (TTM)

$1.58B

EPS (TTM)

$1.34

P/E Ratio

22.58

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$30.19

Volume

250

Open

$30.19

Price

$30.19

Volume

250

Open

$30.19

Previous Close

$30.19

Daily Range

$30.19 - $30.19

52-Week Range

$14.00 - $32.84

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$30.19

Volume

250

Open

$30.19

Previous Close

$30.19

Daily Range

$30.19 - $30.19

52-Week Range

$14.00 - $32.84

TEVJF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Teva Pharmaceutical Industries

Industry

Pharmaceuticals

Sector

Health Care

Employees

33,346

CEO

Richard Francis

Website

www.tevapharm.com

Headquarters

Tel Aviv, 6944020, IL

TEVJF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

19%

Net Income Margin

Return on Equity

22%

Return on Capital

13%

Return on Assets

Earnings Yield

4.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$35.16B

Shares Outstanding

1.16B

Volume

250

Avg. Volume

6.313

Financials (TTM)

Gross Profit

$9.75B

Operating Income

$2.16B

EBITDA

$5.43B

Operating Cash Flow

$3.10B

Capital Expenditure

$542.32M

Free Cash Flow

$2.56B

Cash & ST Invst.

$3.56B

Total Debt

$17.09B

Teva Pharmaceutical Industries Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$3.98B

+2.3%

Gross Profit

$1.97B

+5.1%

Gross Margin

49.52%

N/A

Market Cap

$35.16B

N/A

Market Cap/Employee

$950.28K

N/A

Employees

37,000

N/A

Net Income

$369.00M

+72.4%

EBITDA

$990.18M

+29.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$13.17B

+13.6%

Accounts Receivable

$3.39B

+0.3%

Inventory

$3.18B

-2.2%

Long Term Debt

$14.34B

-13.2%

Short Term Debt

$2.61B

+520.4%

Return on Assets

3.90%

N/A

Return on Invested Capital

12.62%

N/A

Free Cash Flow

$208.00M

+10.3%

Operating Cash Flow

$40.00M

+61.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OTSKFOtsuka Holdings Co., Ltd.

OTSKFOtsuka Holdings Co., Ltd.$64.57+0.00%

ALPMYAstellas Pharma Inc.

ALPMYAstellas Pharma Inc.$14.21-1.52%

ORINYOrion Oyj

ORINYOrion Oyj$37.99+0.00%

SAUHYStraumann Holding AG

SAUHYStraumann Holding AG$11.39-0.70%

TRUMFTerumo Corporation

TRUMFTerumo Corporation$11.60+0.00%

SGIOFShionogi & Co., Ltd.

SGIOFShionogi & Co., Ltd.$17.68+0.00%

CLPBYColoplast A/S

CLPBYColoplast A/S$6.31-3.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About TEVJF

What is the current price of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries is trading at $30.19 per share.

What is the 52-week range for Teva Pharmaceutical Industries?

Over the past 52 weeks, Teva Pharmaceutical Industries has traded between $14.00 and $32.84.

How much debt does Teva Pharmaceutical Industries have?

As of the most recent reporting period, Teva Pharmaceutical Industries reported total debt of $16.91B.

How much cash does Teva Pharmaceutical Industries have on hand?

Teva Pharmaceutical Industries reported $3.74B in cash and cash equivalents in its most recent financial results.

What is Teva Pharmaceutical Industries’s dividend yield?

Teva Pharmaceutical Industries does not currently have a dividend yield.

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Financials at a Glance

TEVJF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Teva Pharmaceutical Industries

TEVJF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Teva Pharmaceutical Industries Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TEVJF

What is the current price of Teva Pharmaceutical Industries?

What is the 52-week range for Teva Pharmaceutical Industries?

How much debt does Teva Pharmaceutical Industries have?

How much cash does Teva Pharmaceutical Industries have on hand?

What is Teva Pharmaceutical Industries’s dividend yield?

Premium Investing Services